Amgen Inc. (AMGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Amgen Inc. (AMGN)

AMGN 297.00

+0.2%

Nov 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (1304)	10/11/2006 8:51:19 PM
From: tuck	of 1906

>>Anyone know what happened to AMG-108 (anti IL1) ?<< You remember this whiffed in osteoarthritis, right? The RA trial is still ongoing. Note info was updated by Amgen in October of 2006: clinicaltrials.gov Still, this commenced about two years ago. With the endpoint miss in OA, it's probably a good thing that apparently no p value is being sacrificed for an interim look, hence no news. I suspect enrollment has been slow, since there are several agents out there that work reasonably well, as you know. I wouldn't put it in your valuation model, or, if you are looking at it from the perspective of a competitor, I wouldn't view it as a serious or impending threat. Investor relations might give more detail -- such as when further information is expected -- if you care enough to call? Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next